Erratum: Cannabinoid receptor 2 signalling bias elicited by 2,4,6-trisubstituted 1,3,5-triazines (Frontiers in Pharmacology (2018) 9 (1202) DOI: 10.3389/fphar.2018.01202)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Due to a production error, 24 references with more than six authors were listed in the Reference list without “et al.” The references affected are Bouaboula et al. (1993, 1996); Felder et al. (1995); Galiegue et al. (1995); Favata et al. (1998); Portier et al. (1999); Kilts et al. (2002); Karsak et al. (2005); Wright et al. (2005); Ofek et al. (2006); Jiang et al. (2007); Valant et al. (2008); Cencioni et al. (2010); Hurst et al. (2010); Schuehly et al. (2011); van der Stelt et al. (2011); Kleyer et al. (2012); Odan et al. (2012); Shonberg et al. (2013); Brailoiu et al. (2014); Herenbrink et al. (2016); Finlay et al. (2017); Soethoudt et al. (2017) and Yrjölä et al. (2015). The publisher apologizes for this mistake. The original version of this article has been updated.

Cite

CITATION STYLE

APA

Office, F. P. (2019). Erratum: Cannabinoid receptor 2 signalling bias elicited by 2,4,6-trisubstituted 1,3,5-triazines (Frontiers in Pharmacology (2018) 9 (1202) DOI: 10.3389/fphar.2018.01202). Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2019.00418

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free